Asia Pacific Stem Cells Market Size & Outlook, 2024-2030
Asia Pacific stem cells market, 2018-2030 (US$M)
Related Markets
Asia Pacific stem cells market highlights
- The Asia Pacific stem cells market generated a revenue of USD 2,774.6 million in 2024.
- The market is expected to grow at a CAGR of 16.4% from 2025 to 2030.
- In terms of segment, adult stem cells was the largest revenue generating product in 2024.
- Induced Pluripotent Stem Cells is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 2,774.6 million |
| Market revenue in 2030 | USD 6,901.6 million |
| Growth rate | 16.4% (CAGR from 2024 to 2030) |
| Largest segment | Adult stem cells |
| Fastest growing segment | Induced Pluripotent Stem Cells |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells |
| Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 16.8% of the global stem cells market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 6,901.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Stem Cells Market Scope
Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stem cells market will help companies and investors design strategic landscapes.
Adult stem cells was the largest segment with a revenue share of 83.8% in 2024. Horizon Databook has segmented the Asia Pacific stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific stem cells market is projected to grow at the highest CAGR due to the increasing patient population in the region and the growing need for fast-track regulatory approval processes for cell-based products.
In recent years, China witnessed significant progress in the advancement of human pluripotent stem cell (hPSC)-based products for numerous applications. In March 2021, China National Stem Cell Resource Center was awarded the region’s first biobank accreditation certificate.
It is the first ISO 20387-approved biobank acknowledged for its stem cell resource at the global level. The certification process assists regulators to establish a standardized process in biobanks and ensure the sample quality, encourages international exchange, and forms a foundation for the utilization and conservation of genetic material.
Reasons to subscribe to Asia Pacific stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific stem cells market databook
-
Our clientele includes a mix of stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific stem cells market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific stem cells market size, by country, 2018-2030 (US$M)
Asia Pacific Stem Cells Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
